Ranbaxy, a pharmaceutical major and FMCG manufacturer Proctor and Gamble (P&G) are among nine companies that have been allowed to set up units in Himachal Pradesh.
 
"Ranbaxy and Procter and Gamble (P&G) Monday got permission from the state government to set up units in the ...

Malvinder Singh has resigned as the chairman, managing director and chief executive of India's largest pharmaceutical company, Ranbaxy Laboratories. While confirming the news of Malvinder Singh's, the company informed that the current chief operating officer Atul Sobti has been given the charge of ...

Leading drug manufacturing company of India, Ranbaxy Laboratories Ltd has acquired Ochoa Laboratories’ skin care and lifestyle brands for an undisclosed amount. While making the announcement on Thursday (May 21), Ranbaxy stated that it has acquired trademarks, product dossiers and marketing ...

Ranbaxy Laboratories’ Paonta Sahib factory today (24th March) won good manufacturing certification from British and Australian drug regulators. Ranbaxy said  that, UK's Medicines and Healthcare Products Regulatory Agency (MHRA) and Australia's Therapeutic Goods Administration (TGA) ...

Ranbaxy Laboratories, India's largest drugmaker, has received marketing approval to sell the low-cost version of GlaxoSmithKine's anti-migrane drug, Imitrex (Sumatriptan) in USA.
 
The USFDA has given approval for sell of Imitrex in 100 mg dosage with 180-day marketing exclusivity. Earlier ...

Ranbaxy Laboratories and its new owner Japan’s Daiichi Sankyo, which now holds 63.92% of Ranbaxy’s equity share capital, reconstituted a new 10-member panel. Besides persisting in with his existing duties as CEO & MD, Malvinder Mohan Singh has been nominated as the chairman of ...

The import of more than 30 generic drugs manufactured by Ranbaxy, India's largest pharmaceutical company, has been blocked by the United States on grounds of poor quality at its two factories. Among the banned Ranbaxy drugs also includes popular antibiotic Cipro and cholesterol pill Zocor. ...

Japanese drug manufacturer Daiichi Sankyo Company Ltd has announced that it will pay Rs.737 per share to shareholders of Ranbaxy Laboratories in its open offer coming on Aug 16. Earlier, Indian government approved Daiichi Sankyo's stake purchase in Ranbaxy Laboratories last week.
 
This ...

Japanese drug manufacturing company Daiichi Sankyo has said that its open offer to acquire 92.5 million share at Rupees 5 each might change. The announcement has been made by ICICI Securities which is managing the open offer.  This has come in aftermath of Ranbaxy’s takeover by ...

The generic versions of the Anglo-Swedish pharmaceutical company, Astrazeneca’s anti-ulcer drug Prilosec 40 mg will be introduced by India’s Ranbaxy Laboratories Limited in the United States. The Anglo-Swedish pharmaceutical company made Ranbaxy a legal generics partner following an ...

Daiichi Sankyo Company Ltd, which is a major Japanese pharmaceutical company, is going to acquire a majority stake in Ranbaxy Laboratories Ltd., the largest drug manufacturer in India. The two have declared a binding share purchase and share subscription agreement (SPSSA) between Daiichi Sankyo, ...